[ad_1]
Telehealth platform Teladoc Health expands its collaboration with Microsoft to integrate the tech giant’s AI solutions into its platform, enabling providers to automate the creation of clinical documentation during virtual exams.
The virtual care company will integrate Microsoft Azure OpenAI Service, Azure Cognitive Services and a conversational and ambient clinical documentation solution nuance Dragon Ambient eXperience (DAX) in Teladoc Health Solo. Solo is an enterprise platform that can be integrated with existing IT systems to deliver virtual care.
Teladoc Health Medical Group will also use Nuance DAX Express for its Teladoc Health care visits. DAX Express is an AI-powered clinical documentation application that will combine Nuance’s capabilities with Open AI GPT4 in the Azure OpenAI service, enabling coordinated care by transferring documentation to other clinicians.
THE virtual care company stock rose amid news of the expanded partnership.
“Administrative burden and staffing shortages are the main reasons clinicians are leaving the profession,” Dr. Vidya Raman-Tangella, Teladoc Health’s chief medical officer, said in a statement. “We are focused on using AI to reaffirm and build the doctor-patient relationship in a time when technology often does the opposite. We are proud to partner with Microsoft and Nuance to innovate.”
THE GREAT TREND
In 2021, Teladoc and Microsoft announced their partnership to streamline telehealth technology and administrative processes by offering Solo in the Microsoft Teams environment for healthcare systems and hospitals.
The same year, Microsoft acquired conversational artificial intelligence and ambient clinical intelligence platform Nuance in a cash transaction totaling $19.7 billion.
In March, Microsoft’s Nuance Communications announced its clinical documentation toolDragon Ambient eXperience Express, using the latest version of Open AI artificial intelligence language model, GPT-4, launched earlier this year. Nuance’s tool is based on the company’s DAX documentation product, launched in 2020.
Last week, a federal judge dismissed a securities class action lawsuit filed in 2022 against Teladoc Health by shareholder Jeremy Schneider on behalf of the parties who purchased Teladoc shares between February 2021 and July 2022.
The lawsuit concerned the virtual care company $18.5 billion merger with chronic care platform Livongo, alleging that its representatives misled investors by downplaying the challenges it faced when integrating Livongo. He also claimed the company made misleading statements and “artificially inflated Teladoc’s stock price” during those 17 months.
[ad_2]
Source link
